| Literature DB >> 25867715 |
P Brady1, N Brison1, K Van Den Bogaert1, T de Ravel1, H Peeters1, H Van Esch1, K Devriendt1, E Legius1, J R Vermeesch1.
Abstract
Non-invasive prenatal testing (NIPT) for fetal aneuploidy detection is increasingly being offered in the clinical setting. Whereas the majority of tests only report fetal trisomies 21, 18 and 13, genome-wide analyses have the potential to detect other fetal, as well as maternal, aneuploidies. In this review, we discuss the technical and clinical advantages and challenges associated with genome-wide cell-free fetal DNA profiling.Entities:
Keywords: cell-free DNA, (cfDNA); cell-free fetal DNA, (cffDNA); copy number variation, (CNV); genome sequencing; mosaicism; non-invasive prenatal testing, (NIPT); prenatal diagnosis
Mesh:
Substances:
Year: 2015 PMID: 25867715 DOI: 10.1111/cge.12598
Source DB: PubMed Journal: Clin Genet ISSN: 0009-9163 Impact factor: 4.438